A single-dose, crossover, placebo- and moxifloxacin-controlled study to assess the effects of neratinib (HKI-272) on cardiac repolarization in healthy adult subjects. Background: Schedules with ...
Liposomal daunorubicin and cytarabine (CPX-351) was effective in relapsed acute myeloid leukemia, but long-term follow-up is needed to determine the extent of the agent's cardiotoxicity. In a study of ...
PHOENIX, AZ, Jan 26, 2015 (Marketwired via COMTEX) -- Insys Therapeutics, Inc. INSY, +0.10% a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug ...
A recent article published in Applied Surface Science Advances describes the bioprinting of nanostructured patches composed of sodium alginate (NaAlg), polyvinyl alcohol (PVA), and indocyanine green ...
Insys Therapeutics, Inc. (NASDAQ: INSY), a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug delivery systems, today announced that the U.S. Food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback